Old drug, new hope: common antibiotic could shield TB patients from lifelong lung damage
NCT ID NCT05473520
Summary
This study is testing if adding a common antibiotic called doxycycline to standard tuberculosis (TB) treatment can protect patients' lungs and heart from long-term damage. It will involve 150 adults with active TB who have just started treatment. The goal is to see if this extra drug helps preserve lung function, heal lung cavities faster, and reduce the risk of future heart problems.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Queen Elizabeth I
NOT_YET_RECRUITINGKota Kinabalu, Sabah, Malaysia
Contact
Contact Email: •••••@•••••
-
Klinik Kesihatan Luyang
ACTIVE_NOT_RECRUITINGKota Kinabalu, Sabah, Malaysia
-
Klinik Kesihatan Menggatal
RECRUITINGKota Kinabalu, Sabah, Malaysia
Contact Phone: •••-•••-••••
Contact Phone: •••-•••-••••
-
National University Hospital
RECRUITINGSingapore, 119228, Singapore
Contact Email: •••••@•••••
-
TB Control Unit
RECRUITINGSingapore, Singapore
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Universiti Malaysia Sabah (UMS), Borneo Medical and Health Research Centre
ACTIVE_NOT_RECRUITINGKota Kinabalu, Sabah, Malaysia
Conditions
Explore the condition pages connected to this study.